In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes
Mayne KJ., Herrington WG.
SOURCE CITATION: Agarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474-84. 35023547.